while rhodium and iridium complexes exhibited N∩N bonding mode with the migration of the N H proton to the adjacent C O (keto) group forming enol. Anti-bacterial activity studies (against Gram-positive and Gram-negative bacteria) as well as anti-cancer [HCT116 p53 wild type (p53+/+) and HCT116 p53 null (p53−/−)] were carried out for all the complexes as well as ligands where interestingly, ligand L2
摘要通过使
金属前体[(
芳烃)MC
L2] 2(
芳烃=对甲基异丙基苯,Cp *; M = Ru,Rh和Ir)与苯并zone衍
生物配体L1,
L2和L3反应合成了配合物1–9 PF6为抗衡离子的阳离子络合物的制备
钌配合物表现出N = O键合模式,而
铑和
铱配合物表现出N = N键合模式,其中NH质子迁移到相邻的CO(酮)基团形成烯醇。对所有复合物均进行了抗菌活性研究(针对革兰氏阳性和革兰氏阴性细菌)以及抗癌药[HCT116 p53野生型(p53 + / +)和HCT116 p53 null(p53-/-)]。有趣的是,
配体L2和配合物5对两种
生物学研究都显示出高活性(体外)。在Ru,Rh和Ir中,